EKSO (Ekso Bionics Holdings) Cyclically Adjusted Book per Share: $31.11 (As of Mar. 2026)


EKSO Ekso Bionics Holdings Inc EKSO
32 GF Score
Price $11.65
GF Value $4.36
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Ekso Bionics Holdings Cyclically Adjusted Book per Share?

Ekso Bionics Holdings EKSO -0.42% 32 Cyclically Adjusted Book per Share is $31.11 as of Mar. 2026. GuruFocus rates EKSO with a GF Score™ of 32/100 and a GF Value™ of $4.36 (Significantly Overvalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Ekso Bionics Holdings's adjusted book value per share for the three months ended in Mar. 2026 was $0.587. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $31.11 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ekso Bionics Holdings's average Cyclically Adjusted Book Growth Rate was -31.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 66.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Ekso Bionics Holdings was 145.20% per year. The lowest was 66.80% per year. And the median was 106.00% per year.

As of today (2026-07-03), Ekso Bionics Holdings's current stock price is $11.65. Ekso Bionics Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $31.11. Ekso Bionics Holdings's Cyclically Adjusted PB Ratio of today is 0.37.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Ekso Bionics Holdings was 13.00. The lowest was 0.06. And the median was 1.31.


Ekso Bionics Holdings  (NAS:EKSO) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ekso Bionics Holdings's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=11.65/31.11
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Ekso Bionics Holdings was 13.00. The lowest was 0.06. And the median was 1.31.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Ekso Bionics Holdings Cyclically Adjusted Book per Share Related Terms


Ekso Bionics Holdings Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Ekso Bionics Holdings's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ekso Bionics Holdings Cyclically Adjusted Book per Share Chart

Ekso Bionics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.52 7.12 9.21 51.90 33.07

Ekso Bionics Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.06 39.95 36.56 33.07 31.11

EKSO vs POCI, HBIO, NEPH: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ekso Bionics Holdings Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's Cyclically Adjusted PB Ratio falls into.


EKSO
32GF Score
Ekso Bionics Holdings Inc EKSO
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ekso Bionics Holdings Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ekso Bionics Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.587/330.2130*330.2130
=0.587

Current CPI (Mar. 2026) = 330.2130.

Ekso Bionics Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201606 16.606 241.018 22.751
201609 66.894 241.428 91.494
201612 51.833 241.432 70.893
201703 -10.976 243.801 -14.866
201706 10.926 244.955 14.729
201709 111.530 246.819 149.213
201712 80.417 246.524 107.717
201803 55.369 249.554 73.265
201806 28.244 251.989 37.012
201809 20.097 252.439 26.289
201812 9.743 251.233 12.806
201903 15.113 254.202 19.632
201906 16.228 256.143 20.921
201909 19.282 256.759 24.798
201912 17.609 256.974 22.628
202003 13.405 258.115 17.149
202006 -0.054 257.797 -0.069
202009 15.164 260.280 19.238
202012 7.961 260.474 10.092
202103 48.549 264.877 60.524
202106 47.507 271.696 57.739
202109 46.282 274.310 55.714
202112 43.994 278.802 52.106
202203 39.119 287.504 44.930
202206 36.596 296.311 40.783
202209 32.702 296.808 36.383
202212 28.911 296.797 32.166
202303 23.940 301.836 26.191
202306 19.355 305.109 20.948
202309 16.077 307.789 17.248
202312 12.733 306.746 13.707
202403 11.651 312.332 12.318
202406 9.804 314.175 10.304
202409 10.136 315.301 10.615
202412 8.586 315.605 8.983
202503 6.751 319.799 6.971
202506 4.196 322.561 4.296
202509 3.690 324.800 3.751
202512 2.536 324.054 2.584
202603 0.587 330.213 0.587

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $31.11 mean?
Ekso Bionics Holdings (EKSO) has a Cyclically Adjusted Book per Share of $31.11 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Ekso Bionics Holdings and its competitors.
Is Ekso Bionics Holdings' Cyclically Adjusted Book per Share too high?
Ekso Bionics Holdings' current Cyclically Adjusted Book per Share is $31.11. Overall, Ekso Bionics Holdings has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ekso Bionics Holdings' Cyclically Adjusted Book per Share compare to POCI and HBIO?
Ekso Bionics Holdings' Cyclically Adjusted Book per Share of $31.11 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Ekso Bionics Holdings and its competitors. Ekso Bionics Holdings's current Cyclically Adjusted Book per Share is $31.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ekso Bionics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ekso Bionics Holdings (EKSO) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.36, compared to a current price of $11.65 — trading 167.2% above its estimated fair value. The current Cyclically Adjusted Book per Share is $31.11. Ekso Bionics Holdings' overall GF Score™ is 32/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Ekso Bionics Holdings (EKSO), the current Cyclically Adjusted Book per Share is $31.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ekso Bionics Holdings (EKSO) Overvalued in 2026?

Based on GuruFocus' analysis, Ekso Bionics Holdings stock appears to be overvalued. The current stock price of $11.65 is trading 167.2% above its estimated GF Value™ of $4.36. GuruFocus considers Ekso Bionics Holdings to be Significantly Overvalued.

Key valuation signals for EKSO:

  • Cyclically Adjusted Book per Share: $31.11
  • GF Value™: $4.36 vs. price of $11.65 (167.2% above fair value)
  • GF Score™: 32/100 with 10 warning signs

No single metric tells the full story. See the EKSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ekso Bionics Holdings Business Description

Address 101 Glacier Point, Suite A, San Rafael, CA, USA, 94901
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
32GF Score

Get the complete analysis for EKSO

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.65
Price
$4.36
GF Value